The early bird offer for the World Drug Safety Congress Americas is coming to an end today- Friday, 9th March. Register before the end of today to save up to $155!
Learn how to overcome the increased regulatory requirements, implement effective risk management, maintain and strengthen communication with stakeholders, address post marketing safety issues and more at the World Drug Safety Congress Americas 2012. This meeting will provide you with key insights into drug safety challenges and give you an excellent opportunity to discuss these diverse issues in a conference format.
Hear from Ronald Leong- AstraZeneca, George McCormick- Teva Pharmaceuticals, Milbhor D' Silva- Astellas, Paul Beninger- Genzyme, all previously featured on our blog, as well as experts from from Abbott, Roche, Boehringer Ingelheim, Forest Laboratories, Health Canada and Pfizer as they gather together to discuss innovative drug safety solutions.
The programme includes streams on global drug safety setting, risk management strategies, safety data management, safety in early development, clinical safety, post authorisation safety, safety in special populations, drug safety: best practice, safety in large molecules and infrastructure requirements. Visit our website for the full programme or to register.